United States· US:71209-099_85ff09b7-6b73-44bd-a654-11fbab9efdbe
OFLOXACIN
A ofloxacin product containing ofloxacin, registered in United States by Cadila Pharmaceuticals Limited. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Ofloxacin is registered in 10 of 19 countries.
Countries holding a registration under ATC J01MA01 (ofloxacin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Ofloxacin · ATC J01MA01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OFLOXACIN
- Manufacturer
- Cadila Pharmaceuticals Limited
- Country
- United States (US)
- ATC code
- J01MA01
- ATC class
- Ofloxacin
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 6
- ndc117120909902100 TABLET, FILM COATED in 1 BOTTLE (71209-099-02)
- ndc117120909905500 TABLET, FILM COATED in 1 BOTTLE (71209-099-05)
- ndc11712090991050 TABLET, FILM COATED in 1 BOTTLE (71209-099-10)
- ndc1171209-099-02
- ndc1171209-099-05
- ndc1171209-099-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
596 interactions on record for ofloxacin.
Graded by severity as the source publishes them — 86 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ofloxacin · interactions on record
596 records
- 86 severe
- 216 moderate
- 51 minor
- 170 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PrednisoloneA07EA01severe
73 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ofloxacin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumOfloxacine EG 400 mgEG
- NetherlandsOfloxacine 400 PCH, filmomhulde tabletten 400 mgPharmachemie B.V.
- United KingdomExocin 0.3% eye dropsSigma Pharmaceuticals Plc
- PolandFloxalDelfarma Sp. z o.o.
- GermanyFloxalDr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh
- FranceEXOCINE 0,3 POUR CENT, collyreABBVIE
- Japanオフロキサシン参天製薬
- SpainEXOCIN 3 MG/ML COLIRIO EN SOLUCIONAbbvie Spain, S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Floxal, Floxal Edo
- Belgium · Trafloxal, Trafloxal Edo
- Bulgaria · Медофлоксин, Офлоксацин Дра
- Cyprus · Cilox, Medofloxine
- Czechia · Floxal, Ofloxacin Unimed Pharma
- Germany · Floxal, Floxal Edo
- Estonia · Medofloxine, Ofloxin
- Spain · Exocin, Oflovir
- Finland · Exocin
- France · Exocine, Monoflocet
- United Kingdom (Northern Ireland) · Exocin, Ofloxacin Bristol Laboratories
- Greece · Exocin, Oxatrex
- Croatia · Uniflox
- Hungary · Floxal, Grenis-Oflo
- Ireland · Exocin
- Italy · Dunaflot, Exocin
- Lithuania · Ofloxin, Uniflox
- Luxembourg · Ofloxa-Vision Kombi-Packung, Visioflox
- Latvia · Ofloxin, Uniflox
- Malta · Uniflox Unimed Pharma
- Netherlands · Ofloxacine 200 Pch, Ofloxacine 400 Pch
- Poland · Floxal, Oflodinex
- Portugal · Audret, Bioquil
- Romania · Floxal, Ofloxacină Laropharm
- Sweden · Ofloxacin Mibe
- Slovakia · Medofloxine, Ofloxin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/faaa085a-5e80-45e2-bd13-b9788b0405b7 GET /v1/drugs/faaa085a-5e80-45e2-bd13-b9788b0405b7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "400",
"substance": "OFLOXACIN",
"productndc": "71209-099",
"dosage_form": "TABLET, FILM COATED",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA091656",
"marketing_category": "ANDA"
}See everything about ofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.